Actinium Enhances Capabilities with Hiring of Industry and Clinical Research Veterans to its Product Development and Clinical Development Teams NEW YORK, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...

Inform Genomics Transplant Product Shown to Predict Oral Mucositis with a High Degree of Accuracy in Patients Undergoing Conditioning Regimens Prior to Hematopoetic Stem Cell Transplant Boston, MA, Dec. 11, 2012 (GLOBE NEWSWIRE) --  Inform Genomics, Inc., a private company focused on developing novel platforms of genomic-based personalized medicine products for cancer supportive...